VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.
Position in BSX — Boston Scientific Corp
CIK 1367401
AMSTERDAM, P7
Position in BSX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,051,100
-$13,421,072 QoQ
Shares Held
94,918
-65.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#445
of 1,462 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. holds $104,078,163 across 6 Medical Devices names. BSX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
633,450 | $49,554,793 | |
| 2 | ABT |
Abbott Laboratories
|
190,590 | $17,294,136 | |
| 3 | EW |
Edwards Lifesciences Corp
|
158,935 | $14,377,260 | |
| 4 | QDEL |
QuidelOrtho Corp
|
647,069 | $11,336,648 | |
| 5 | SYK |
Stryker Corp
|
23,708 | $7,464,226 | |
| 6 | BSX |
Boston Scientific Corp
This page
|
94,918 | $4,051,100 |
All Filings in BSX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,051,100 | 94,918 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,472,172 | 278,441 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,179,772 | 274,565 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,256,103 | 135,779 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,876,336 | 101,260 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||